Humanised anti platelet glycoprotein (GPIb) monoclonal antibodies

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHumanised anti platelet glycoprotein (GPIb) monoclonal antibodies
Drug Alias NameTGX 6B4Fab 6B4Humanised anti glycoprotein Ib murine monoclonal antibodies research programme-ThromboGenicsTGX6B4Humanised murine anti-GP Ib-Mab 6B4-ThromboGenics +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGlycoprotein Ib platelet beta subunit antagonists
TargetsGlycoprotein Ib platelet beta subunit
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of LeuvenThrombogenics IncLife Sciences Research Partners
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A